Yale study identifies racial and ethnic disparities in Oncotype DX testing for women

[News]

In a simple definition, cancer is a disease of the cells, which is caused by gene mutations. For a proportion of patients, including women with hormone receptor positive (HR+) breast cancer, gene expression profiling has a substantial impact on treatment decision-making by determining which patients might—or might not—respond to particular treatment options.

More... (http://www.news-medical.net/news/20170317/Yale-study-identifies-racial-and-ethnic-disparities-in-Oncotype-DX-testing-for-women-with-breast-cancer.aspx)